ECLIPSE 2 is one of three trials in Vir Biotechnology’s registrational ECLIPSE program for CHD, which was initiated in March 2025 .

Concept Medical Announces First Patient Enrollment In MAGICAL-SV IDE Trial, Expanding Its Coronary Clinical Program Across The US And Europe This first enrollment marks a major milestone in the ...

Whether you're creating short videos for social media or working on a feature-length film, the right editing software is essential. We've tested and rated the best video editing software for all ...

This first enrollment marks a major milestone in the company’s mission to revolutionize coronary artery disease (CAD) treatment and expands Concept Medical’s clinical program into the United ...